September 2019

Neurovalens a Clarendon portfolio company based in Belfast are embarking on the development of a ground-breaking medical device for the treatment of obesity. The company specialises in combining neuroscience and technology to tackle global health challenges such as obesity, diabetes and sleep disorders. The investment in research and development will be accompanied by the creation […]

A decade of empathic technology knowledge deployed in a box to accelerate automotive innovation Clarendon portfolio company Sensum launches the SynsisTM Empathic Technology Developer Kit, the world’s first sensor-fusion kit for measuring real-time human states from body, face and voice data combined. Synsis equips automotive OEMs, tier one suppliers and simulator companies with a single